TY - JOUR
T1 - TGF-β regulates invasive behavior of human pancreatic cancer cells by controlling Smad expression
AU - Sawai, Hirozumi
AU - Yasuda, Akira
AU - Ochi, Nobuo
AU - Takahashi, Hiroki
AU - Wakasugi, Takehiro
AU - Azuma, Masaaki
AU - Matsuo, Yoichi
AU - Funahashi, Hitoshi
AU - Sato, Mikinori
AU - Akamo, Yoshimi
AU - Takeyama, Hiromitsu
AU - Manabe, Tadao
PY - 2007/9
Y1 - 2007/9
N2 - Introduction: To investigate the role of Smads in tumor cell activation, we examined changes in Smad expression as well as changes in proliferative and invasive behaviors in transforming growth factor-β (TGF-β) - stimulated pancreatic cancer cells. Material and methods: Expression of TGF-β receptortype I (TβR-I) and type II (TβR-II) was determined using RT-PCR and Western blot analysis in the human pancreatic cancer cell lines BxPC-3, Capan-2, and PANC-1. TGF-β-mediated changes in Smad mRNA expression were examined using quantitative real-time RT-PCR. Proliferation of pancreatic cancer cells was monitored using an MTT assay and cell counting. Invasive behavior was examined using a Matrigel double-chamber assay. Results: TβR-1 and TβR-II were expressed in all three cell lines studied here at the mRNA and protein level. Smad2/3 mRNA expression was decreased after TGF-β stimulation in all three cell lines, while Smad4 mRNA expression remained unchanged. Smad6/7 mRNA expression was also attenuated in all three cell lines. TGF-β enhanced the invasive capacity of all three cell lines, but had no effect on the proliferative behavior. Anti-TβR-II antibody inhibited this TGF-β-enhanced invasive potential in pancreatic cancer cells. Conclusions: The Smad pathway, particularly down-regulation of Smad2/3 and Smad6/7, may be responsible for TGF-β-induced invasion of human pancreatic cancer cells.
AB - Introduction: To investigate the role of Smads in tumor cell activation, we examined changes in Smad expression as well as changes in proliferative and invasive behaviors in transforming growth factor-β (TGF-β) - stimulated pancreatic cancer cells. Material and methods: Expression of TGF-β receptortype I (TβR-I) and type II (TβR-II) was determined using RT-PCR and Western blot analysis in the human pancreatic cancer cell lines BxPC-3, Capan-2, and PANC-1. TGF-β-mediated changes in Smad mRNA expression were examined using quantitative real-time RT-PCR. Proliferation of pancreatic cancer cells was monitored using an MTT assay and cell counting. Invasive behavior was examined using a Matrigel double-chamber assay. Results: TβR-1 and TβR-II were expressed in all three cell lines studied here at the mRNA and protein level. Smad2/3 mRNA expression was decreased after TGF-β stimulation in all three cell lines, while Smad4 mRNA expression remained unchanged. Smad6/7 mRNA expression was also attenuated in all three cell lines. TGF-β enhanced the invasive capacity of all three cell lines, but had no effect on the proliferative behavior. Anti-TβR-II antibody inhibited this TGF-β-enhanced invasive potential in pancreatic cancer cells. Conclusions: The Smad pathway, particularly down-regulation of Smad2/3 and Smad6/7, may be responsible for TGF-β-induced invasion of human pancreatic cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=35449005284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35449005284&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:35449005284
SN - 1734-1922
VL - 3
SP - 185
EP - 191
JO - Archives of Medical Science
JF - Archives of Medical Science
IS - 3
ER -